#Gastroparesis

2 stories

Regulatory April 15, 2026 · View digest

Ozempic MDL Hits 3,363 Cases as Critical Daubert and Summary Judgment Deadlines Approach

The GLP-1 mass tort litigation (MDL 3094) before Judge Karen Marston in the Eastern District of Pennsylvania now includes 3,363 cases alleging gastroparesis and other injuries. Expert discovery closed in late March, with Daubert motions due April 28 and summary judgment motions due April 30. A Science Day on vision loss claims is set for June 2.

Regulatory March 24, 2026 · View digest

GLP-1 Lawsuits Surpass 3,500 Pending Cases as Vision Loss Claims Surge

Over 3,546 lawsuits are now consolidated in two federal MDLs — one for gastroparesis and one for NAION vision loss. On March 3, a federal judge appointed lead counsel for the NAION MDL. Studies show semaglutide users face a fourfold increase in NAION risk, with vision loss claims now generating more legal attention than earlier gastroparesis cases.